Products for regulation of eukaryotic and microbial cells growth
OwnerVictor TETS, Georgy TETSinventors
Life of this patent
Estimating the term…
Abstract
The invention relates to methods for the flexible regulation of cellular growth of eukaryotic and prokaryotic cells. In particular embodiments. regulation of eucaryotic and microbial cells growth, occurs by the control of their interaction with the environmental factors, nutrient media, media additives, supplements.
Claims36
The product wherein automatic and/or semiautomatic station for the preparation of test-systems of different constructions, and/or test-systems and/or Bio adjustable Tetz incubators, and/or CO2 incubators and/or bioreactors and/or incubator-warm rooms of different construction for cultivation of microorganisms and/or cell cultures with and/or nutrient media, and/or media additives and/or supplements, differs in that enables individually to prepare media with programmed composition in relation to the object of study and/or regulate, control interaction of microorganisms and eucaryotic cells with physical, chemical, biological environmental factors, and/or alter growth rate of different not-yet culturable bacteria, and/or fungi within mixed microbial communities.
The methods for preparation of test-systems of different construction and/or cultivation of microorganisms with the use of nutrient media, media additives and supplements, methods of their usage, differs in that enables individually to prepare media with programmed composition in relation to the object of study and/or regulate, control interaction of microorganisms and eucaryotic cells with physical, chemical, biological environmental factors, and/or alter growth rate of different with a non-limiting examples not-yet culturable bacteria, fungi within mixed microbial communities, alter and/or enhance microbial and/or eukaryotic cells growth and/or synthetic activity, and/or determine the effect of antimicrobial drugs on them to select effective and/or ineffective antimicrobial agents and/or combinations thereof including those with as narrow as possible spectrum of action and/or with the highest safety profile and/or cheapest and/or with certain route of administration active against (1) drug resistant microorganisms and/or (2) the existing persisters or persisters that can be formed in the course of antibiotic therapy of the infection and/or sporeforming bacteria, (3) recurrent infections done by (3) simultaneous analysis of combinational effect of antimicrobial agents on Primary Pathogen (PP) and Microorganisms Modulators (MM), as well as devices and methods of accounting for the results of these actions, wherein said sample comprising at least one of fluid, water, food, beverage, biofluid, tissue, microbial probes, a pharmaceutical preparation, a mammalian sourced tissue and liquids, air, soil, surface, swabs, and any combination thereof for the use in biopharmaceutical manufacturing, medicine, veterinary, agriculture, bioengineering, drug development and discovery, ecology, space exploration, space technology, persons with altered metabolic parameters that alters the pharmacokinetics and pharmacodynamics of drugs and/or children in particular
Dependencies are inferred from the claim text.